Results 121 to 130 of about 23,301 (197)

Case Report: Durable remission of intraocular mantle cell lymphoma after CD19 CAR-T therapy. [PDF]

Front Immunol
Bienert-García Á, Arruabarrena C, Asencio-Duran M, Arias MM, Baumann T, Izquierdo AR, Sánchez-Pina JM, López-Muñoz N, Gil-Alós D, Saez-Marín AJ, Calbacho M, Martínez-López J, Jiménez-Ubieto A.   +12 more
europepmc   +1 more source

Clinical characteristics, treatment patterns, and survival in mantle cell lymphoma: a real-world cohort. [PDF]

Front Oncol
de la Hoz C, Hurtado-Otiz A, Licht-Ardila M, Cantillo A, Silva A, Herrera L, Alvarez P, Vega Jiménez OD, Fonseca J, Mendoza-Monsalve A, Avila JA, Manrique-Hernández EF.   +11 more
europepmc   +1 more source

Comprehensive analysis of mortality risk factors in low-grade B-cell lymphoma. [PDF]

PLoS One
Kim TY, Min GJ, Cho SG, Kim S, Lee JH, Kim BS, Jeoung JW, Won HS, Jeon Y.   +8 more
europepmc   +1 more source

Five-year follow-up of patients with relapsed/refractory mantle cell lymphoma treated with anti-CD19 CAR T-cell therapy in ZUMA-2, Cohorts 1 and 2. [PDF]

J Hematol Oncol
Muñoz J, Locke FL, Reagan PM, Goy A, Jacobson CA, Hill BT, Timmerman JM, Flinn IW, Miklos DB, Pagel JM, Kersten MJ, Forcade E, Topp MS, Houot R, Beitinjaneh A, Zheng D, Chang M, Zhang W, Shen RR, Khalid RD, Kloos I, Wang ML.   +21 more
europepmc   +1 more source

Transforming mantle cell lymphoma: the journey across eras. [PDF]

Haematologica
Castonguay M, Seymour JF.
europepmc   +1 more source

A novel immune model predicts the prognosis of mantle cell lymphoma. [PDF]

Front Med (Lausanne)
Hao X, Zhang Y, Qi W, Zhu M, Wang J, Yang P, Zhang W, Jing H.   +7 more
europepmc   +1 more source

Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphoma. [PDF]

Hemasphere
Albiol N, Martínez-Cibrián N, Pérez AI, Navarro-Velázquez S, Muzzi G, Oliver-Caldes A, Español-Rego M, Alserawan L, Montoro-Lorite M, Ramos C, Ayora P, Martin-López AÁ, Cabero A, Pérez-López E, García-Sancho AM, Baumann T, Sánchez-Pina JM, Chinea A, Fernández-Caldas P, Bastos-Oreiro M, Kwon M, Rodríguez-Lobato LG, Magnano L, Rivero A, Correa JG, Mozas P, Sánchez-Castañón M, Mata-Molanes JJ, Charry P, Álamo JR, Setoaín X, Rodríguez S, Olesti E, Sáez-Peñataro J, Fernández de Larrea C, Urbano-Ispizua Á, López-Guillermo A, Delgado J, González-Navarro EA, Juan M, Giné E, Ortiz-Maldonado V.   +41 more
europepmc   +1 more source

Impact of rituximab maintenance on survival in patients with mantle cell lymphoma: a population-based cohort study. [PDF]

Blood Adv
Stedema F, Brink M, Huisman F, van Rijn R, Sijs-Szabo A, Nijhof I, Diepstra A, Vergote V, van Gorkum G, Flinsenberg T, Huls G, van Meerten T, Doorduijn J, Plattel W, Nijland M.   +14 more
europepmc   +1 more source

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy. [PDF]

Blood Cancer J
Wang Y, Larson MC, Hwang SR, Villa D, Kugathasan L, Kumar A, Joseph A, Brooks TR, Hill BT, Bond DA, Maddocks KJ, Danilov A, Argao C, Ruan J, Nizamuddin IA, Kahl BS, Grover NS, Khan NB, Pongas GN, Lossos IS, Ouchveridze E, Tun AM, Baidoun F, Alhaj Moustafa M, Harris ZI, Munoz JL, Young PR, Portell CA, Reagan PM, Ryan CE, Merryman RW, Velayati A, Greenwell IB, Gerber DG, Jain P, Wang ML, Ayyappan SR, Mou E, Banaszak LG, Pophali PA, Stack AC, Messmer MR, Narkhede MS, Mehta A, Moyo TK, Ghosh N, Bhansali RS, Barta SK, Kamdar MK, Anna J, Stanisic AV, Karmali R, Maurer MJ, Cerhan JR, Cohen JB, Martin P.   +55 more
europepmc   +1 more source

Composite Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Diagnostic and Therapeutic Challenge. [PDF]

EJHaem
Ye MT, Yang Y, You MJ.
europepmc   +1 more source